Business Context and Reporting Period
Promis Neurosciences Inc. (PMN) filed this Form 8-K on June 29, 2023, to report the results of its 2023 Annual Meeting of Shareholders. The company is incorporated in Canada and trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Voting Results
Shareholders voted on three proposals at the Annual Meeting. Approximately 93.51% of total outstanding shares (Common and Preferred) were present or represented by proxy.
- Proposal 1 (Election of Directors): All eight nominees were elected. Notable vote counts included Eugene Williams (3,320,369 For) and William Wyman (3,048,981 For). There were 914,356 broker non-votes.
- Proposal 2 (Auditor Ratification): Shareholders ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023 (4,294,824 For vs. 99,591 Against).
- Proposal 3 (Continuance to Ontario): Shareholders approved the continuance of the company to the jurisdiction of the Province of Ontario under the Business Corporations Act (Ontario) (4,537,149 For vs. 103,948 Against).
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results.
Investor Verification Checklist
- Verify the final composition of the Board of Directors following the election of the eight nominees.
- Confirm the effective date of the company's continuance to the Province of Ontario.
- Review the definitive proxy statement filed on June 1, 2023, for detailed biographies of the elected directors and further context on the auditor appointment.
- Check subsequent filings for the company's next financial report to obtain revenue and cash flow data not present in this 8-K.